Compounds > gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate
Page last updated: 2024-09-03

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Graft Occlusion, Vascular

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Graft Occlusion, Vascular in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Froehlich, JM; Hoogeveen, R; Kistler, T; Mende, KA; von Weymarn, C; Wentz, KU; Zollikofer, CL1

Other Studies

1 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Graft Occlusion, Vascular

ArticleYear
Time-resolved, high-resolution contrast-enhanced MR angiography of dialysis shunts using the CENTRA keyhole technique with parallel imaging.
    Journal of magnetic resonance imaging : JMRI, 2007, Volume: 25, Issue:4

    Topics: Adult; Aged; Arm; Arteriovenous Shunt, Surgical; Contrast Media; Female; Graft Occlusion, Vascular; Heterocyclic Compounds; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Angiography; Male; Middle Aged; Organometallic Compounds; Prospective Studies; Renal Dialysis

2007